2019 Neonatal Respiratory Distress Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 115 pages | ID: 2B4A1561A99EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Neonatal Respiratory Distress Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Neonatal Respiratory Distress Syndrome. It presents in-depth analysis of Neonatal Respiratory Distress Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Neonatal Respiratory Distress Syndrome.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Neonatal Respiratory Distress Syndrome clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Neonatal Respiratory Distress Syndrome

The research work is prepared through extensive and continuous research on Neonatal Respiratory Distress Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Neonatal Respiratory Distress Syndrome patients are identified
• The report includes panorama of Neonatal Respiratory Distress Syndrome clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Neonatal Respiratory Distress Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Neonatal Respiratory Distress Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Neonatal Respiratory Distress Syndrome Clinical Trials by Region
  2.2.2 Average Enrollment of Neonatal Respiratory Distress Syndrome Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Neonatal Respiratory Distress Syndrome Treatment, 2019

3. REGION WISE NEONATAL RESPIRATORY DISTRESS SYNDROME CLINICAL TRIALS

3.1 Asia Pacific Neonatal Respiratory Distress Syndrome Clinical Trials by Country
3.2 Europe Neonatal Respiratory Distress Syndrome Clinical Trials by Country
3.3 North America Neonatal Respiratory Distress Syndrome Clinical Trials by Country
3.4 Middle East and Africa Neonatal Respiratory Distress Syndrome Clinical Trials by Country
3.5 South and Central America Neonatal Respiratory Distress Syndrome Clinical Trials by Country

4. NEONATAL RESPIRATORY DISTRESS SYNDROME CLINICAL TRIAL TRENDS

4.1 Start Year wise Neonatal Respiratory Distress Syndrome Clinical Trials
4.2 Phase wise Neonatal Respiratory Distress Syndrome Clinical Trials
4.3 Trial Status wise Neonatal Respiratory Distress Syndrome Clinical Trials
4.4 Trial Type wise Neonatal Respiratory Distress Syndrome Clinical Trials

5. NEONATAL RESPIRATORY DISTRESS SYNDROME AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Neonatal Respiratory Distress Syndrome Trials by Year
5.2 Average Enrollment in Neonatal Respiratory Distress Syndrome Trials by Phase
5.3 Average Enrollment in Neonatal Respiratory Distress Syndrome Trials by Status
5.4 Average Enrollment in Neonatal Respiratory Distress Syndrome Trials by Type of Trial

6. COMPANIES PARTICIPATING IN NEONATAL RESPIRATORY DISTRESS SYNDROME CLINICAL TRIALS

6.1 Neonatal Respiratory Distress Syndrome Trials by Sponsor Type
6.2 Neonatal Respiratory Distress Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Neonatal Respiratory Distress Syndrome Trials- Phase
7.2 Neonatal Respiratory Distress Syndrome Trials- Phase
7.3 Neonatal Respiratory Distress Syndrome Trials- Phase
7.4 Neonatal Respiratory Distress Syndrome Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Neonatal Respiratory Distress Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 5: Europe – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 7: North America – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Figure 9: Neonatal Respiratory Distress Syndrome Clinical Trials by Phase
Figure 10: Neonatal Respiratory Distress Syndrome Clinical Trials by Trial Status
Figure 11: Neonatal Respiratory Distress Syndrome Clinical Trials by Type
Figure 12: Neonatal Respiratory Distress Syndrome Clinical Trials by Sponsor Type
Figure 13: Neonatal Respiratory Distress Syndrome Clinical Trials by Leading Sponsors
Figure 14: Neonatal Respiratory Distress Syndrome Average Enrollment by Phase
Figure 15: Neonatal Respiratory Distress Syndrome Average Enrollment by Trial Status
Figure 16: Neonatal Respiratory Distress Syndrome Average Enrollment by Type
Figure 17: Neonatal Respiratory Distress Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Neonatal Respiratory Distress Syndrome- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Neonatal Respiratory Distress Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 5: Europe – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 7: North America – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Neonatal Respiratory Distress Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Neonatal Respiratory Distress Syndrome Average Enrollment by Phase
Table 15: Neonatal Respiratory Distress Syndrome Average Enrollment by Trial Status
Table 16: Neonatal Respiratory Distress Syndrome Average Enrollment by Type
Table 17: Neonatal Respiratory Distress Syndrome- Average Enrolment by Type of Sponsors
Table 18: Neonatal Respiratory Distress Syndrome- Enrolment by Leading Sponsors